Effects of sodium ferulate on Aβ25-35-induced cognitive deficits and expression of IL-1β and p38MAPK in rats

Chinese Pharmacological Bulletin

Volumn 22, Issue 5, 2006, Pages 602-606

  Jin, Ying ^a   Yan, En Zhi ^a   Fan, Ying ^a   Qi, Zhi Min ^a   Bao, Cui Fen ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Amyloid beta protein; Inflammation; p38MAP kinase; Sodium ferulate

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; FERULIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; IBUPROFEN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BEHAVIOR DISORDER; BRAIN REGION; CELL ACTIVATION; CELL INFILTRATION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MAZE TEST; NISSL STAINING; NONHUMAN; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPATIAL MEMORY; WESTERN BLOTTING;

EID: 33747169640     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories[J]. Neurobiol Aging, 1997, 18 (4):351-7.
2. Minogue A M, Schmid A W, Fogarty M P, et al. Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of Amyloid-β on long term potentiation and cell death in hippocampus. A role for interleukin-1β[J]? J Biol Chem, 2003, 278 (30):27971-80.
3. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimers disease[J]. Neurobiol Aging, 2000,21(3):383-421.
4. Scott B C, Butler J, Halliwell B, Aruoma O I. Evaluation of the antioxidant action of ferulic acid and catechins[J]. Free Radic Res Commun, 1993,19(4):241-53.
5. Fernandez M A, Saenz M T, Garcia M D. Anti-inflammatory activity in rats and mice of phenolic acids isolated from Scrophularia frutescens[J]. J Pharm. Pharmacol, 1998,50(10):1183-6.
6. Yan J J, Cho J Y, Kim H S, et al. Protection against beta-amyloid peptide toxicity in vivo with log-term administration of ferulic acid [J]. Br J Pharmacol, 2001,133(1):89-96.
7. Kim H S, Cho J Y, Kim D H, et al. Inhibitory effects of long-term administration of ferulic acid on microglial activation induced by intracerebroventricular injection of β-amyloid peptide (1-42) in mice[J]. Biol Pharm Bull, 2004,27(1):120-1.
8. Morris R. Development of a water maze procedure for studying spatial learning in the rat[J]. J Neurosci Methods, 1984, 11(1): 47-60.
9. Jin Y, Fan Y, Yan E Z, et al. MAP kinase superfamily in amyloid β-protein fragment 25-35-induced inflammation and apoptosis in rat hippocampus in vivo[J]. Chin J Pharmacol Toxicol, 2005,19 (3):161-8.
10. Giovannini M G, Scali C, Prosperi C, et al, Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway[J]. Neurobiol Dis, 2002, 11(2):257-74.
11. Lim G P, Yang F, Chu T, et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimers disease [J]. Neurosci, 2000,20(15):5709-14.
12. Bellmann K, Burkart V, Bruckhoff J, et al. p38-dependent enhancement of cytokine-induced nitric-oxide synthase gene expression by heat shock protein 70[J]. J Biol Chem, 2000,275(24): 18172-9.
13. Le-Niculescu H, Bonfoco E, Easuya Y, et al. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death[J]. Mol Cell Biol, 1999,19(1):751-63.
14. Morishima Y, Gotoh Y, Zieg J, et al. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand[J]. J Neurosci, 2001,21(19):7551-60.